284 related articles for article (PubMed ID: 33653375)
1. Second trimester maternal serum D-dimer combined with alpha-fetoprotein and free β-subunit of human chorionic gonadotropin predict hypertensive disorders of pregnancy: a systematic review and retrospective case-control study.
Chen Y; Chen Y; Wang X; Chu X; Ning W; Gu L; Li L; Xie Z; Wen C
J Transl Med; 2021 Mar; 19(1):94. PubMed ID: 33653375
[TBL] [Abstract][Full Text] [Related]
2. Predicting Hypertensive Disease in the First Trimester of Pregnancy: Risk Models and Analysis of Serum D-dimer Levels Combined with Plasma Pregnancy-Associated Protein A, Free
Chen Y; Ning W; Chu X; Chen Y; Gu L; Xie Z; Li L; Wen C; Wang X
Biomed Res Int; 2022; 2022():8264958. PubMed ID: 35402610
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18.
Chen Y; Chen Y; Ning W; Zhang W; Li L; Wang X; Yin Y; Zhang H
Sci Rep; 2022 Aug; 12(1):13605. PubMed ID: 35948592
[TBL] [Abstract][Full Text] [Related]
4. [The value of maternal first and second trimester serum data of β-hCG, PAPP-A, AFP and uE3 in the prediction of preeclampsia].
Gu W; Lin J; Hou Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):101-7. PubMed ID: 25877605
[TBL] [Abstract][Full Text] [Related]
5. Construction and predictive value of risk models of maternal serum alpha-fetoprotein variants and fetal open neural tube defects.
Chen Y; Wang X; Chen Y; Ning W; Chen L; Yin Y; Zhang W; Lian J; Wang H
Exp Biol Med (Maywood); 2022 May; 247(10):822-831. PubMed ID: 35238224
[TBL] [Abstract][Full Text] [Related]
6. A Risk Model for Predicting Fetuses with Trisomy 21 Using Alpha-Fetoprotein Variants L2 Combined with Maternal Serum Biomarkers in Early Pregnancy.
Chen Y; Wu B; Chen Y; Ning W; Zhang H
Reprod Sci; 2022 Apr; 29(4):1287-1295. PubMed ID: 34750768
[TBL] [Abstract][Full Text] [Related]
7. Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels.
Räty R; Koskinen P; Alanen A; Irjala K; Matinlauri I; Ekblad U
Prenat Diagn; 1999 Feb; 19(2):122-7. PubMed ID: 10215068
[TBL] [Abstract][Full Text] [Related]
8. A risk prediction model for fetal hypospadias by testing maternal serum AFP and free beta-HCG.
Chen Y; Huang J; Mei J
Clin Biochem; 2019 Jul; 69():21-25. PubMed ID: 31152694
[TBL] [Abstract][Full Text] [Related]
9. [Predictive value analysis of Down's screening serological indicators in the second trimester for gestational hypertension].
Feng C; Liu XW; Wang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Jun; 55(6):747-751. PubMed ID: 34139815
[No Abstract] [Full Text] [Related]
10. Second trimester prenatal screening for Down's syndrome in Mainland Chinese subjects using double-marker analysis of α-fetoprotein and β-human chorionic gonadotropin combined with measurement of nuchal fold thickness.
Liu F; Liang H; Jiang X; Zhang Y; Xue L; Yang C; Cheng J; Liu P; Liu Y; Guo X
Ann Acad Med Singap; 2011 Jul; 40(7):315-8. PubMed ID: 21870022
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of alpha-fetoprotein variants L2 and L3 as substitutes of alpha-fetoprotein in screening for fetal Trisomy 18.
Chen Y; Ning W; Wang H; Chen Y; Huang J; Wen L; Hu W
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6764-6769. PubMed ID: 33980109
[TBL] [Abstract][Full Text] [Related]
12. Early Prediction of Hypertensive Disorders of Pregnancy Using Cell-Free Fetal DNA, Cell-Free Total DNA, and Biochemical Markers.
Kim SY; Kim HJ; Park SY; Han YJ; Choi JS; Ryu HM
Fetal Diagn Ther; 2016; 40(4):255-262. PubMed ID: 26998901
[TBL] [Abstract][Full Text] [Related]
13. Comparison of second-trimester maternal serum free-beta-human chorionic gonadotropin and alpha-fetoprotein between normal singleton and twin pregnancies: a population-based study.
Zheng MM; Hu YL; Zhang CY; Ru T; Liu QL; Xu BY; Chen QG; Xu ZF; Zhang Y; Zhong XL
Chin Med J (Engl); 2010 Mar; 123(5):555-8. PubMed ID: 20367980
[TBL] [Abstract][Full Text] [Related]
14. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
15. The role of serum markers PAPP-A β-hCG, AFP, and uE3 in predicting the risk of preeclampsia in early, middle, and late pregnancy.
Zhang W; Liang H
Technol Health Care; 2023; 31(3):1027-1037. PubMed ID: 36442168
[TBL] [Abstract][Full Text] [Related]
16. A risk model of prenatal screening markers in first trimester for predicting hypertensive disorders of pregnancy.
Chen Y; Xie Z; Wang X; Xiao Q; Lu X; Lu S; Shi Y; Lv S
EPMA J; 2020 Sep; 11(3):343-353. PubMed ID: 32849925
[TBL] [Abstract][Full Text] [Related]
17. Maternal Serum PLGF, PAPPA, β-hCG and AFP Levels in Early Second Trimester as Predictors of Preeclampsia.
Duan H; Zhao G; Xu B; Hu S; Li J
Clin Lab; 2017 May; 63(5):921-925. PubMed ID: 28627818
[TBL] [Abstract][Full Text] [Related]
18. Relationship between increased maternal serum free human chorionic gonadotropin levels in the second trimester and adverse pregnancy outcomes: a retrospective cohort study.
Chen Y; Dai X; Wu B; Jiang C; Yin Y
BMC Womens Health; 2024 Jun; 24(1):323. PubMed ID: 38835013
[TBL] [Abstract][Full Text] [Related]
19. Predictive Value of Second-Trimester Biomarkers and Maternal Features for Adverse Pregnancy Outcomes.
Yefet E; Kuzmin O; Schwartz N; Basson F; Nachum Z
Fetal Diagn Ther; 2017; 42(4):285-293. PubMed ID: 28395283
[TBL] [Abstract][Full Text] [Related]
20. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
Tancrède S; Bujold E; Giguère Y; Renald MH; Girouard J; Forest JC
J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
